Monthly Archives: November 2008

Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study

-  PRESS RELEASE Milestone Marks the First Time a European Patient with Active Celiac Disease has Enrolled in a Clinical Trial for an Investigational Medication from Alba Therapeutics Last update: 8:22 p.m. EST Nov. 11, 2008 BALTIMORE, Nov 11, 2008 /PRNewswire via COMTEX/ — Alba Therapeutics Corporation announced today that for the first time, a European patient with active celiac ...

Read More »

KEEP YOURSELF HEALTHY!

JOIN OUR MAILING LIST!